A group in the US has accused coffee franchise Starbucks of surreptitiously
spiking its chai tea with ephedrine, a stimulant related to amphetamines and linked to
strokes and heart attacks. Starbucks (who, incidentally, will soon be
saturation-bombing Melbourne with outlets) denies the claim.